Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China flag China · Delayed Price · Currency is CNY
16.48
-0.13 (-0.78%)
Nov 18, 2026, 3:00 PM CST

SHA:600521 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
945.75266.41,119830.471,168487.54
Depreciation & Amortization
998.02998.02916.77780.37672.01563.07
Other Amortization
26.6926.6915.89.257.082.45
Loss (Gain) From Sale of Assets
-0-0-2.330.29-3.59-0.6
Asset Writedown & Restructuring Costs
53.653.630.1339.4121.6910.35
Loss (Gain) From Sale of Investments
-69.45-69.4597.72161.9766.48-442.95
Provision & Write-off of Bad Debts
-9.03-9.0336.58-7.9345.3714.73
Other Operating Activities
590.06393.59229.27241.6986.91220.3
Change in Accounts Receivable
-126.34-126.34-786.09269.5-818.89-388.87
Change in Inventory
-471.61-471.61-78.33-140.05-679.92-386.81
Change in Accounts Payable
165.02165.02597.6819.99669.89679.92
Change in Other Net Operating Assets
8.318.3114.14-0.4981.61113.74
Operating Cash Flow
2,1061,2302,1732,2171,243938.43
Operating Cash Flow Growth
122.22%-43.38%-2.00%78.41%32.42%-39.67%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,859-1,966-1,853-1,592-2,316-2,434
Sale of Property, Plant & Equipment
34.079.955.24.8410.729.94
Cash Acquisitions
-6.53-----
Investment in Securities
35.4386.27-72.57-18.7-106.6658.19
Other Investing Activities
16.122.280.43-16.53-20.359.48
Investing Cash Flow
-1,628-1,868-1,920-1,623-2,433-2,357

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-4,7266,2023,3213,8733,238
Long-Term Debt Repaid
--4,337-5,637-3,321-2,732-1,931
Lease Payments
-33.41-33.41-21.53-22.17-21.78-16.16
Net Debt Issued (Repaid)
791.21388.58564.79-0.61,1401,307
Issuance of Common Stock
-591.52--37.68371.82
Repurchase of Common Stock
---189.92-71-172.43-150.01
Common Dividends Paid
-327.02-546.18-475.36-556.01-318.32-387.21
Other Financing Activities
-22.05183.16-32.42-16.63-78.36-23.31
Financing Cash Flow
442.14617.07-132.91-644.23609.041,118

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-150.21-10.6551.162954.65-43.49
Net Cash Flow
770.1-31.05170.63-20.98-526.18-343.57

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
246.86-735.96319.33624.63-1,074-1,496
Free Cash Flow Growth
---48.88%---
Free Cash Flow Margin
2.57%-8.57%3.35%7.52%-12.99%-22.52%
Free Cash Flow Per Share
0.16-0.500.220.43-0.73-1.04
Levered Free Cash Flow
-381.18-887.07-478.3615.26-1,715-1,721
Unlevered Free Cash Flow
-231.01-741.07-340.99160.07-1,578-1,617
Free Cash Flow After Leases
213.45-769.37297.8602.47-1,095-1,512

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.060.060.060.060.060.06
Cash Income Tax Paid
312.04391.44568.31614.3206.43227.84
Change in Working Capital
-429.72-429.72-270.27161.5-821.0283.55